Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.
Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...
Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.
The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...
The US joins Moldova, Hong Kong, and New Zealand as countries to greenlight the company's Phase I trial of PBGENE-HBV.
Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...
Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular ...
“No drug should pass through inland borders but only through ... So clearly, this is a public health issue and the health of ...